Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.53
-0.0900-1.60%
Post-market: 5.530.00000.00%19:20 EDT
Volume:1.37M
Turnover:7.45M
Market Cap:299.64M
PE:-1.54
High:5.70
Open:5.61
Low:5.26
Close:5.62
Loading ...

Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

THOMSON REUTERS
·
16 Dec 2024

Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

THOMSON REUTERS
·
16 Dec 2024

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GlobeNewswire
·
16 Dec 2024

BlueOne Card Expands with Millennium EBS Acquisition

TIPRANKS
·
14 Dec 2024

DEXIS Attends ADF, Showcases Award-Winning Solutions

ACCESSWIRE
·
28 Nov 2024

Envista Announces Release of 2023 Sustainability Report

PR Newswire
·
21 Nov 2024

Envista Announces Participation in Evercore HealthCONx Conference

PR Newswire
·
20 Nov 2024

First mpox case linked to African outbreak reported in U.S.

seekingalpha
·
17 Nov 2024

Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)

seekingalpha
·
16 Nov 2024

Russia says African, ex-Soviet countries interested in its mpox vaccine

Reuters
·
13 Nov 2024

Emergent BioSolutions files to sell 3.61M shares of common stock for holders

TIPRANKS
·
13 Nov 2024

Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

Stock Track | Emergent BioSolutions Stock Soars 8.73% on Impressive Q3 Earnings and CEO Confidence

Stock Track
·
08 Nov 2024

Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
08 Nov 2024

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Benzinga
·
08 Nov 2024

Emergent Biosolutions Shares Surge 28% After Swinging to 3Q Profit

Dow Jones
·
08 Nov 2024